Clinical trial

Prospective, Randomized Trial of Ticagrelor Versus Prasugrel in Patients With…

NCT01944800 · Deutsches Herzzentrum Muenchen, Other · Completed

Key facts

NCT number NCT01944800
Title Prospective, Randomized Trial of Ticagrelor Versus Prasugrel in Patients With Acute Coronary Syndrome
Official title Prospective, Randomized Trial of Ticagrelor Versus Prasugrel in Patients With Acute Coronary Syndrome - Intracoronary Stenting and Antithrombotic Regimen: Rapid Early Action for Coronary Treatment (ISAR-REACT) 5
Acronym ISAR-REACT 5
Lead sponsor Deutsches Herzzentrum Muenchen, Other
Collaborators Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK)
Status Completed
Phase Phase 4
Study type Interventional
Conditions Acute Coronary Syndrome (ACS)
Intervention type Drug
Interventions Ticagrelor, Prasugrel
Enrollment 4,018
Start date Sep 15, 2013
Primary completion Jul 1, 2019
Completion Sep 1, 2021
First posted Sep 18, 2013
Last update posted Feb 6, 2023
Countries Germany, Italy

At a glance

  • 10–99 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies